ArticleOncology reports2017

In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells.

Florencia Paula Madorsky Rowdo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.